A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
Clinical trial NCT00773513 · COMPLETED
Trial details
- NCT number
- NCT00773513
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-12
- Primary completion
- 2017-07-27
- Enrollment
- 2825
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.